<DOC>
	<DOCNO>NCT01357031</DOCNO>
	<brief_summary>The purpose study determine effectiveness melatonin 3 mg compare placebo amitriptyline 25 mg preventive treatment migraine .</brief_summary>
	<brief_title>Study With Amitriptylin Evaluate Efficacy Melatonin Treatment Migraine</brief_title>
	<detailed_description>The investigator propose study patient migraine ( episodic ) without aura , accord criterion International Headache Society ( IHS ) 2004 . This randomized clinical trial , prospective , double-blind , placebo-controlled , compare efficacy melatonin 3 mg amitriptyline 25 mg migraine prevention . The length inclusion study 24 month . This study 's general objective : evaluate effectiveness melatonin preventive treatment migraine compare placebo amitriptyline .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Man woman 18 65 year age . Meets diagnostic criterion criteria International Headache Society ( IHS ) 2004 ( 2 ) migraine / without aura . Frequency 2 8 migraine attack per month Top crisis year age onset less 50 year age . Patients want participate study , able give inform consent . If woman , patient must willing use acceptable method birth control ( eg , hormonal contraceptive , intrauterine device , diaphragm spermicide condom spermicide , refer abstinence ) . Patient able willing remain medication throughout study . Accept guideline study fill diary clinical scale . Any medical condition place patient risk exposure melatonin amitryptiline Use alcohol drug . Be receive prophylactic medication last three month . History hemiplegic migraine , basilar , Ophthalmoplegic stroke . Headache secondary head trauma whiplash neck injury ( whiplash ) . Pregnant breastfeeding . Women plan become pregnant childbearing age without acceptable method contraception . Women begin take oral contraceptive switch oral contraceptive regimen 6 month prior start study . Allergy known hypersensitivity study medication component . Participation another clinical study one month inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Amitriptyline</keyword>
	<keyword>Placebo</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Drug therapy</keyword>
	<keyword>Preventive treatment migraine</keyword>
</DOC>